Christine Elisabet Dietinger

Title: Christine Elisabet Dietinger: Innovator in Therapeutic Dendrimers

Introduction

Christine Elisabet Dietinger is a prominent inventor based in Abbotsford, Australia. She has made significant contributions to the field of therapeutic dendrimers, which are innovative molecules with potential applications in cancer treatment. Her work focuses on the development of dendrimers that can effectively deliver therapeutic agents to target diseases.

Latest Patents

Christine holds a patent for a therapeutic dendrimer. This invention comprises a core unit and five generations of building units made from lysine residues or their analogues. The dendrimer features first terminal groups that include a residue of a camptothecin active covalently attached to a diglycolyl linker group, along with second terminal groups that comprise a PEG group. Additionally, her patent includes pharmaceutical compositions that utilize these dendrimers and outlines methods for their use in treating disorders such as cancers. The processes for making the dendrimers and their intermediates are also detailed in her patent.

Career Highlights

Christine is associated with Starpharma Pty Limited, a company known for its innovative approaches in the pharmaceutical industry. Her work at Starpharma has allowed her to explore the therapeutic potential of dendrimers and contribute to advancements in drug delivery systems.

Collaborations

Christine has collaborated with notable colleagues, including Brian Devlin Kelly and David James Owen. These partnerships have enhanced her research and development efforts in the field of dendrimer technology.

Conclusion

Christine Elisabet Dietinger is a trailblazer in the development of therapeutic dendrimers, with a focus on improving cancer treatment methodologies. Her innovative work and collaborations continue to pave the way for advancements in pharmaceutical applications.